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  INVESTIGATION OF FORCED AND TOTAL 
DEGRADATION PRODUCTS OF AMLODIPINE 
BESYLATE BY LIQUID CHROMATOGRAPHY 
AND LIQUID CHROMATOGRAPHY-MASS 
SPECTROMETRY 
Article Highlights 
• Amlodipine besylate stock solutions were subjected to stressed conditions 
• Acid and alkali hydrolysis, chemical oxidation and photodegradation were used 
• Electrochemical degradation by cyclic voltammetry was also studied 
• LCMS was used for the investigation of the degradation products 
• Total degradation of amlodipine besylate was achieved in 5 mol/L NaOH at 80 °C for 
6 h 
 
Abstract 
An isocratic, reversed-phase liquid chromatographic method was applied for 
the investigation of the degradation products of amlodipine besylate under 
stressed conditions in solution. Amlodipine besylate stock solutions were sub-
jected to acid and alkali hydrolysis, chemical oxidation and photodegradation, 
as well as to the electrochemical degradation by cyclic voltammetry in 0.05 
mol/L NaHCO3 on gold electrode. The total degradation of amlodipine besylate 
was achieved in 5 mol/L NaOH at 80 °C for 6 h and the compound with mole-
cular formula C15H16NOCl was identified as a main degradation product. Under 
acidic (5 mol/L HCl at 80 °C for 6 h) stress conditions 75.2% of amlodipine 
besylate degradation was recorded. Oxidative degradation in a solution of 3% 
H2O2:methanol 80:20 at 80 °C for 6 h showed that amlodipine besylate deg-
raded to 80.1%. After 14 days of expose in photostability chamber amlodipine 
besylate solution showed degradation of 32.2%. In electrochemical degrad-
ation, after 9 h of cyclization the beginning of amlodipine oxidation was shifted 
for 200 mV to more negative potentials, with the degradation of 66.5%. Mass 
spectrometry analysis confirmed the presence of dehydro amlodipine derivate 
with molecular formula C20H23N2O5Cl in oxidative and acidic conditions, while 
in electrochemical degradation was detected in traces. 
Keywords: amlodipine besylate, forced degradation, reversed phase 
liquid chromatography, liquid chromatography-mass spectrometry. 
 
 
Amlodipine, R,S-2-[(2-aminoethoxy)methyl]-4-
(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbo-
nyl-6-methyl-1,4-dihydropyridine is a calcium channel 
blocking agent with a long duration of action, widely 
used against hypertension and angina [1,2]. It was 
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originally marketed in tablet form by Pfizer as a bes-
ylate salt under the trade name Norvasc [3] and gen-
eric amlodipine besylate tablets have been launched 
by different manufacturers in Europe over the last ten 
years [4]. Amlodipine besylate (Figure 1) belongs to 
the one of the most worldwide prescript cardiovas-
cular drugs. 
The identification and qualification of degrad-
ation products in pharmaceuticals is important since 
impurities may cause the undesirable effects on the 
patients and on the other hand may have influence on 
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quality, safety and efficacy of the drug product. The 
International Conference on Harmonization (ICH) has 
issued the Guidelines regarding qualification of impu-
rities in drug substance and products as well as stab-
ility testing for registration of pharmaceutical for 
human use [5-7]. ICH Guidelines [8] also require the 
implementation of stress testing procedures for the 
identification of degradation products that are poten-
tially occurring in drug substances, which can help to 
understand the possible degradation pathway for the 
drugs. This is important from the aspect of product 
formulation, the choice of packaging material and the 
drug product storage conditions. 
 
Figure 1. Structure of amlodipine besylate. 
Amlodipine is photosensitive and undergoes an 
easy light-induced aromatization to pyridine deriva-
tive, as do other 1,4-dihydropyridine compounds 
[9,10]. The photostability and stability of amlodipine in 
liquid dosage forms have been also reported [11,12]. 
Regarding the stability and compatibility of amlodipine 
besylate in its solid formulations with different drug 
excipients, the influence of excipients and storage 
conditions on amlodipine besylate stability has been 
investigated. The major degradation product is amlo-
dipine besylate glycosyl due to a well-known Maillard 
reaction between primary amines (amlodipine) and 
lactose as a water-soluble excipient [13]. The struc-
tural analysis of the Maillard reaction product was 
performed by LC-MS. 
Photostability of amlodipine has also been moni-
tored in several pharmaceutical inclusion systems 
characterized by plurimolecular aggregation of the 
drug and excipients with high molecular weight includ-
ing cyclodextrins, liposomes and microspheres. Such 
matrixes prevent drug oxidation to the aromatic deri-
vative through a number of chemical and physical 
barriers. These systems have shown a high degree of 
protection with a degradation rate always lower than 
in the usual solid drug formulations [14,15]. Thermal 
degradation of amlodipine base affords a mixture of 
three cyclic degradation products all resulting by intra-
molecular cyclisation reactions [16].  
Different analytical methods have been deve-
loped for the study of stressed degradation behavior 
of pharmaceutical active substances and amlodipine 
besylate including spectrophotometric method [17], 
HPTLC [18,19], HPLC [20-23], RP-HPLC [24-27], 
UPLC [28], CE [29] and LC-2D-NMR/LC-MS [30]. 
Forced degradation studies show that amlodipine is 
degrading slowly under thermal stress conditions [16], 
degrading faster under photo stress - more rapidly 
under 366 than under 254 nm [10] and even more 
under acidic, alkaline and oxidative stress conditions 
[21]. The aim of this work is investigation of forced 
degradation of amlodipine besylate under the different 
stressed conditions in solution in order to achieve the 
total degradation of amlodipine besylate. 
EXPERIMENTAL 
Apparatus 
An Agilent 1100 series HPLC system equipped 
with a binary pump, 1200 Diode Array Detector, 
column thermostat, thermostatted autosampler and 
Spherisorb ODS1 column (250.0 mm×4.0 mm id, 5 
µm particle size) was used. The effluents were moni-
tored at 237 nm. Chemstation 32 software was used 
for the data acquisition. All the drugs and chemicals 
were weighed on a Sartorius AC 121S electronic bal-
ance (Sartorius Goettingen, Germany). A UV light 
cabinet Camag (Made in Switzerland) for forced deg-
radation at 366 nm was used. Photodegradation pro-
cesses were performed in a light cabinet type PSC 
062 (Weiss Gallenkamp, UK) equipped with both the 
cool white fluorescent and near ultraviolet lamp, 
according to the ICH Guideline for photostability test-
ing (option 2, ICH Q1B, 1996) [31]. In the present 
study, the power was maintained to 0.66 W/m2 and 
9.85 kLux during 14 days in order to achieve an over-
all illumination of not less than 1.2 million Lux h and 
200 W h/m2. 
Materials and methods 
Amlodipine besylate EP7 quality and  amlodi-
pine besylate CRS (chemical reference standard), 
amlodipine for peak identification, amlodipine impurity 
A, impurity B and impurity G were kindly provided 
from Zdravlje A.D., Actavis Company (Leskovac, Ser-
bia). HPLC grade of methanol and acetonitrile were 
purchased from J.T. Baker. Ammonium acetate, hyd-
rochloric acid, hydrogen peroxide and sodium hydro-
gen carbonate were purchased from Merck. Sodium 
hydroxide was purchased from J.T. Baker. All chemi-
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cal used were of analytical grade. For preparing solu-
tion of ammonium acetate purified water was used. 
LC Analysis 
A Spherisorb ODS1 (octadecylsilyl silica gel) 
column (Waters, 250.0 mm×4.0 mm id, 5 µm particle 
size) was used, and the mobile phase consisted of 
2.3 g/L ammonium acetate solution : methanol (30:70, 
V/V). The flow rate was maintained at 1.5 mL/min for 
related substances peak identification and 1.0 mL/min 
for forced degradation products. The mobile phase 
was passed through a 0.45 µm membrane filter (Sar-
torius Stedim Biotech GmbH, Goettingem, Germany) 
and degassed before use. The elution was monitored 
with diode array detector at 237 nm. The injection 
volume was 20 µl for related substances peak identi-
fication and 100 µl for degradation products. The test 
was carried out protected from light. All the chromato-
graphic separations were carried out at controlled 
room temperature (20–25 °C). 
LC-MS Analysis 
An Agilent 1100 series HPLC system equipped 
with a degasser, autosampler, Waters Spherisorb 
ODS1 column (250.0 mm×4.0 mm id, 5 µm particle 
size) and DAD detector coupled with 6210 Time-of-
Flight LC/MS system (Agilent Technologies) was 
used. An isocratic method (the same like was for LC) 
and the mobile phase consisted of 2.3 g/L of ammo-
nium acetate solution:methanol (30:70, V/V) was 
used. The flow rate was maintained at 1.0 mL/min. 
The injection volume was 100 µL and the column 
temperature was maintained at 30 °C. The chroma-
tograms were monitored at 237 nm. A personal com-
puter system running MassHunter Workstation 
software was used for data acquisition and process-
ing. 
The positively charged molecular ions were 
obtained with electrospray ionization (ESI) at atmo-
spheric pressure. The eluated compounds were mixed 
with nitrogen in the heated nebulizing interface, and 
polarity was tuned to positive with the following ESI 
parameters: capillary voltage 4.0 kV, gas temperature 
350 °C, drying gas flow rate 12 L/min, nebulizer pres-
sure 45 psig (310 Pa), and fragmentor voltage 140 V. 
Mass spectra were acquired over an m/z range of 
100–2000. 
Preparation of stock solution 
Accurately weighed 10 mg of amlodipine besyl-
ate was transferred to a 10 mL volumetric flask and 
dissolved and diluted to the mark with methanol to 
obtain a stock solution of 1000 µg/mL. The freshly 
prepared stock solution was used. 
Procedure for forced degradation study by HPLC 
Preparation of sample solution 
Alkaline degradation. Alkali degradation studies 
were carried out by using of 1 mL of stock solution 
and 9 mL of 0.1 mol/L NaOH. The solution was kept 
at room temperature for a period of 4 h, after which 
the solution was neutralized with 0.1 mol/L hydro-
chloric acid. The solution was diluted to 100 mL with 
mobile phase to prepare the solution of 10 µg/mL. 
The second experiment was carried out by using 
of 1 mL of stock solution and 5 mL of 0.1 mol/L NaOH. 
The solution was kept at 80 °C for 6 h, after which the 
solution was neutralized with hydrochloric acid. The 
solution was diluted to 100 mL with mobile phase to 
prepare the solution of 10 µg/mL. 
The third experiment was carried out by using of 
1 mL of stock solution and 0.2 mL of 5 mol/L NaOH. 
The solution was kept at 80 °C for 6 h, after which the 
solution was neutralized with hydrochloric acid. The 
solution was diluted to 100 mL with mobile phase to 
prepare the solution of 10 µg/mL.  
Degradation in 0.05 mol/L NaHCO3. The solu-
tion of amlodipine besylate was prepared by dissolv-
ing 10 mg of the drug into 100 mL volumetric flask 
with 0.05 mol/L NaHCO3. The freshly prepared drug 
solution was compared with the drug solution, which 
was kept at room temperature for 5 h. 
The another test solution was prepared by dis-
solving 10 mg of the drug into a 100 mL volumetric 
flask with 0.05 mol/L NaHCO3. The solution was kept 
at 80 °C for 5 h (final pH 8.87). The solution was 
diluted to 10 mL with mobile phase to prepare the 
solution of 10 µg/mL. 
Oxidative degradation. For oxidative degrad-
ation studies, initially the solution containing 1 mL of 
stock solution and 9 mL 3% H2O2 was prepared. The 
solution was kept at room temperature for a period of 
24 h, after which the solution was diluted to 100 mL 
with mobile phase to prepare the solution of 10 µg/mL. 
Additionally, two samples for oxidative degrad-
ation were prepared. The studies were carried out by 
using of 1 mL of stock solution and 9 mL solution of 
3% H2O2 : methanol = 80:20 (V/V). The solution was 
kept at 80 °C for a period of 2 h and then for 6 h. After 
that, the solution was diluted to 100 mL with mobile 
phase to prepare the solution of 10 µg/mL. 
Photodegradation. The solution of amlodipine 
besylate was prepared by dissolving 14.3 mg of the 
drug into 100 mL volumetric flask with water.  
5 mL of drug solution was exposed to the long 
wavelength (366 nm) UV light for 2 h and to photo-
degradation as per ICH guidelines for a period of 14 
days (1.2 million Lux h and 200 W h/m2). 
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Procedure for forced degradation study by LC-MS 
In LC-MS procedure for investigation of amlodi-
pine degradation products alkaline, acidic, oxidative 
and electrochemical degradation in 0.05 mol/L NaHCO3 
were included.  
Stock solution. Amlodipine besylate at a concen-
tration of 1 mg/mL in methanol was used in degrad-
ation study. The stock solution of amlodipine besylate 
was subjected to alkali, acidic and oxidative stress 
conditions.  
Alkali degradation. The studies were carried out 
by using of 1 mL of stock solution and 0.2 mL of 5 
mol/L NaOH. The solution was kept at 80 °C for 6 h, 
after which the solution was neutralized with hydro-
chloric acid. The solution was diluted to 100 mL with 
mobile phase to prepare the solution of 10 µg/mL. 
Acidic degradation. The studies were carried out 
by using of 1 mL of stock solution and 0.2 mL of 5 
mol/L HCl. The solution was kept at 80 °C for 6 h, 
after which the solution was neutralized with sodium 
hydroxide. The solution was diluted to 100 mL with 
mobile phase to prepare the solution of 10 µg/mL. 
Oxidative degradation. The studies were carried 
out by using of 1 mL of stock solution and 9 mL 
solution of 3% H2O2:methanol = 80:20 (V/V). The 
solution was kept at 80 °C for 6 h. After that the 
solution was diluted to 100 mL with mobile phase to 
prepare the solution of 10 µg/mL.  
Electrochemical degradation. Electrochemical 
degradation of amlodipine besylate (c = 9.9 µg/mL) 
was carried out by cyclic voltammetry in 0.05 mol/L 
NaHCO3 for 9 h on a gold electrode using equipment 
which has been described in detail [32]. 
RESULTS AND DISCUSSION 
Amlodipine besylate is official in European Phar-
macopoeia [33]. The objective of this study was to 
investigate the amlodipine besylate degradation pro-
ducts under the different stress conditions including 
electrochemical degradation.  
In our preliminary experiment, the forced deg-
radation study was carried out by subjecting amlo-
dipine besylate to alkali hydrolysis, chemical oxide-
tion, photodegradation and degradation in 0.05 mol/L 
NaHCO3 in order to achieve the complete degradation 
of amlodipine besylate. In addition, electrochemical 
degradation was also performed. Results are given in 
Figures 2 and 3, and Tables 1–4. 
Alkali hydrolysis in 0.1 mol/L NaOH performed 
at room temperature for 4 h showed that amlodipine 
besylate was stable under the applied conditions. No 
changes in chromatogram of amlodipine besylate 
were found (Figure 2a). The chromatogram of alkali 
degraded sample in 0.1 mol/L NaOH at 80 °C for 6 h 
showed degradation product peaks at retention times 
(tR) 3.015, 3.538, 4.899 and 5.154 min (Figure 2b). It 
was recorded that 42% of amlodipine besylate was 
degraded. When alkali hydrolysis of amlodipine besyl-
ate was performed in 5 mol/L NaOH at 80 °C for 6 h, 
complete degradation of amlodipine besylate was 
accomplished, with the main degradation product 
peak at retention time 20.878 min (Figure 2c). The 
degradation of the molecule is ascribed to the alkali 
hydrolysis of the acetyl groups of amlodipine [13]. 
Amlodipine besylate degradation was performed 
in 0.05 mol/L NaHCO3 at room temperature for 5 h 
and a degradation of 4.2% in comparison to the 
freshly prepared solution of amlodipine besylate was 
recorded. When amlodipine besylate was degraded in 
0.05 mol/L NaHCO3 at 80 °C for 5 h, 30.7% of amlo-
dipine besylate degradation was recorded. Chromato-
gram (Figure 2d) showed formation of compounds 
with retention times 4.802 and 5.023 min. 
Oxidative degradation (3% H2O2) of amlodipine 
besylate at room temperature for 24 h showed 5.3% 
amlodipine degradation with one degradation product 
peak at retention time 14.337 min. Oxidative degrad-
ation of amlodipine besylate in the solution of 3% 
H2O2:methanol 80:20 (V/V) at 80 °C for 2 h showed 
one degradation peak at retention times 14.335 min 
(Figure 3a) while oxidative degradation (3% H2O2-
methanol 80:20) at 80 °C for 6 h showed three deg-
radation products peak at retention times 7.582, 
14.902 and 31.920 min (Figure 3b). Amlodipine bes-
ylate degradation was increased to 25.9 and 80.1%, 
respectively. 
Chromatogram of amlodipine besylate photo-
degradation performed at 366 nm for 2 h showed 
three degradation products peaks at retention times 
7.516, 10.259 and 14.395 min (Figure 3c) while chro-
matogram of amlodipine besylate photodegradation 
as per ICH guidelines for photostability testing for 14 
days showed two degradation products peak at reten-
tion times 8.205 and 14.867 min (Figure 3d). 
The degradation study thereby indicated that 
amlodipine besylate was found to be stable to alkali 
hydrolysis in 0.1 mol/L NaOH at room temperature for 
4 h, while it was susceptible to degradation in 0.05 
mol/L NaHCO3, oxidative and photo stress conditions.  
Amlodipine besylate in solution showed a 
decrease of 32.2% after 14 days of expose in a 
photostability chamber and 14.1% of decrease at 366 
nm for 2 h.  
According to the literature data [21] amlodipine 
decomposed to 25, 10 and 70% under acidic, neutral 
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(a) 
 
(b) 
 
(c) 
 
(d) 
Figure 2. a) Liquid chromatogram of amlodipine besylate (AMB); chromatograms of alkali treated AMB at 80 °C for 6 h in b) 0.1, 
c) 5 mol/L NaOH and d) chromatogram of alkali treated (0.05 mol/L NaHCO3) AMB at 80 °C for 5 h. 
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(d) 
Figure 3. Chromatogram of oxidative degraded (3% H2O2:methanol = 80:20, V/V) AMB at 80 °C for a) 2  and b) 6 h; c) chromatogram 
showing photodegradation of AMB c) at 366 nm for 2 h and d) as per ICH guidelines for a period of 14 days. 
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and alkaline stress conditions, respectively, and to 
80% under oxidative stress conditions. 
Beside HPLC analysis of amlodipine besylate 
degradation products under stress conditions, LC-MS 
study was performed. The LC-MS procedure included 
alkaline, acidic, oxidative and electrochemical deg-
radation of amlodipine besylate. Electrochemical deg-
radation of amlodipine besylate was performed in 
0.05 mol/L NaHCO3. 
Table 1 shows results of LC-MS analysis of 
amlodipine besylate in alkali degradation (5 mol/L 
NaOH) at 80 °C for 6 h. Forced degradation under 
alkali conditions confirmed the complete degradation 
of amlodipine besylate, while the compound at 
retention time 19.41 min with molecular formula 
C15H16NOCl was found as a main degradation pro-
duct. Molecular mass, found value of m/z ions and 
proposed molecular formula of all potential amlodi-
pine besylate degradation products are given in 
Tables 1–4. 
LC-MS analysis of amlodipine besylate electro-
chemical degradation by cyclic voltammetry (0.05 
mol/L NaHCO3) for 9 h on a gold electrode is given in 
Table 2. The electrochemical experiment indicated 
degradation because after 9 h of cyclization the 
beginning of amlodipine oxidation was shifted for 200 
mV to more negative potentials. Based on liquid chro-
matography results 66.5% of amlodipine besylate 
degradation was achieved. Three degradation pro-
ducts were found at (tR) 7.521 min with the proposed 
molecular formula C21H18N2O6, C23H30N2O5 and 
C18H22N2O7. 
The results of LC-MS analysis of amlodipine 
besylate in acid degradation (5 mol/L HCl) at 80 °C 
for 6 h are summarized in Table 3. Under acidic 
conditions, amlodipine besylate was degraded up to 
75.2% (according to the LC results). It was found that 
the degradation product with molecular formula 
C18H35NO at (tR) 26.84 min is formed at significant 
level. 
Table 1. Results of LC-MS analysis of amlodipine besylate in alkali degradation (5 mol/L NaOH) at 80 °C for 6 h; Identification for 
amlodipine was performed using standard. For other compounds, the proposed molecular formula was determined on the basis of pre-
cisely measured masses; (tr) – traces; compounds detected by mass spectrometer 
No. tR / min Measured molecular mass and measured mass of m/z ions Molecular formula 
1 1.976 348.0823; 349.0895, 100% (351.0851, 30%); 719.1593, 100% 
(721.1577, 30%) + 
+ 406.1296; 407,1369, 100% (409.11351, 30%) 
C11H21O10Cl or C12H17N4O6Cl + 
+ C20H23N2O5Cl or C25H23O3Cl 
2 5.703 472.2546; 473.2619 C21H36N4O8 (tr) 
3 7.461 414.2125; 415.2198 + 394.1149; 395.1222 + 
+378.1408; 379.1480 
C23H30N2O5 (tr) + C21H18N2O6 (tr) +
+C18H22N2O7 (tr) 
4 8.835 278.1491; 279.1563; 301.1384; 317.1142 C16H22O4 (tr) 
5 15.425 246.2170; 247.2238; 264.2509; 269.2065 C14H30O3 (tr) 
6 17.372 290.2436; 291.2507; 308.2772; 313.2332 C16H34O4 (tr) 
7 19.418 261.0900; 262.0973, 100 % (264,0948, 30%) C15H16NOCl 
8 25.078 408.1435; 409.1504, 100% (411.1480, 30%); 431.1328, 100% 
(433.1313, 30%) 
C20H25N2O5Cl (amlodipine) (tr) 
    
Table 2. Results of LC-MS analysis of amlodipine besylate electrochemical degradation by cyclic voltammetry (0.05 mol/L NaHCO3) for 
9 h on gold electrode; Identification for amlodipine was performed using standard. For other compounds, the proposed molecular
formula was determined on the basis of precisely measured masses; (tr) – traces; compounds detected by mass spectrometer 
No. tR / min Measured molecular mass and measured mass of m/z ions Molecular formula 
1 7.521 394.1146; 395.1219 + 414.2132; 415.2196 +  
+ 378.1408; 379.1481 
C21H18N2O6 + C23H30N2O5 + 
+ C18H22N2O7 
2 8.893 278.1494; 279.1566; 301.1387; 317.1138 C16H22O4 (tr) 
3 14.511 406.1274; 407.1347, 100% (409.1333, 30%); 429.1172, 100% 
(431.1175, 30%) 
C20H23N2O5Cl (tr) 
4 15.480 246.2175; 247.2242; 264.2514; 269.2071 C14H30O3 (tr) 
5 17.430 290.2441; 291.2511; 308.2778; 313.2337; 329.2108 + 
+ 348.2971; 349.3044 + 335.3014; 336.3086 
C16H34O4 (tr) + C18H40N2O4 (tr) +
+ C19H37N5 (tr) 
6 19.858 334.2700; 335.2759; 352.3040; 357.2592 C18H38O5 (tr) 
7 25.078 408.1429; 409.1500, 100% (411.1477, 30%); 431.1323, 100% 
(433.1305, 30%); 447.1064, 100% (449.1081, 30%) 
C20H25N2O5Cl (amlodipine) 
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LC-MS analysis of amlodipine besylate oxidative 
degradation (3% H2O2 : methanol 80:20) at 80 °C for 6 
h is given in Table 4. Forced degradation of amlo-
dipine besylate under oxidative conditions also 
showed the presence of compound C18H35NO, as like 
as in acid degradation, at (tR) 26.94 min. Mass 
spectrometry technique confirmed the presence of 
compound with molecular formula C20H23N2O5Cl cor-
responding to dehydro amlodipine derivate [33–35]. 
This compound is one of the forced degradation pro-
ducts in oxidative and acidic conditions, while in elec-
trochemical degradation was found in traces. 
To complete the MS analysis, LC-NMR prepa-
rative isolation of compounds obtained by forced deg-
Table 3. Results of LC-MS analysis of amlodipine besylate in acid degradation (5 mol/L HCl) at 80 °C for 6 h ; Identification for amlo-
dipine was performed using standard. For other compounds, the proposed molecular formula was determined on the basis of precisely 
measured masses; (tr) – traces; compounds detected by mass spectrometer 
No. tR / min Measured molecular mass and measured mass of m/z ions Molecular formula 
1 5.683 455.2278; 456.2397; 473.2616 + 351.1200; 352.1272, 100% 
(354.1125, 30%); 374.1095, 100% (376.1046, 30%); 390.0830, 
100% (392.0822, 30%); 725.2321, 100% (727.2326, 30%); 
C21H33N3O8 + 
+ C18H22NO4Cl or C13H22N3O6Cl 
2 6.648 391.1263; 392.1333, 100% (394.1311, 30%); 414.1159, 100% 
(416.1149, 30%); 430.0911, 100% (432.0893, 30%) 
C19H22N3O7Cl (tr) 
3 7.070 389.0968; 390.1042, 100 % (392.1030, 30 %); 412.0866, 100 % 
(414.0851, 30 %); 428.0594, 100 % (430.0579, 30 %); 801.1903, 
100 % (803.1884, 30 %) 
C15H20N3O7Cl 
4 7.452 414.2121; 415.2194 + 394.1143; 395.1216 + 378.1405; 379.1478 C23H30N2O5 + C21H18N2O6 or 
C16H18N4O8 + C18H22N2O7 
5 8.824 278.1492; 279.1564; 301.1382; 317.1139 C16H22O4 
6 13.736 406.1274; 407.1346, 100% (409.1328, 30%); 429.1172, 100% 
(431.1153, 30%); 445.0905, 100% (447.0906, 30%); 835.2488, 
100 % (837.2469, 30%) + 333.1110; 334.1184, 100% (336.1161, 
30%); 356.1009, 100% (358.0981, 30%) 
C20H23N2O5Cl + 
+ C18H20NO3Cl or C13H20N3O5Cl 
7 15.367 246.2176; 247.2245; 264.2516; 269.2067 C14H30O3 (tr) 
8 17.310 290.2442; 291.2510; 308.2781; 313.2335; 329.2098 C16H34O4 or C17H30N4 
9 19.397 261.0899; 262.0972, 100% (264.2516, 30%) C15H16NOCl (tr) 
10 22.271 348.1227; 349.1300; 371.1115 C19H16N4O3 or C18H20O7 or 
C24H16N2O (tr) 
11 24.868 408.1429; 409.1499, 100% (411.1480, 30%); 431.1323, 100% 
(433.1306, 30%); 447.1064, 100% (449.1085, 30%) 
C20H25N2O5Cl (amlodipine) 
12 26.840 281.2701; 282.2770; 299.3031; 304.2599; 563.5500 C18H35NO 
    
Table 4. Results of LC-MS analysis of amlodipine besylate in oxidative degradation (3% H2O2:methanol, 80:20) at 80 °°C for 6 h; Iden-
tification for amlodipine was performed using standard. For other compounds, the proposed molecular formula was determined on the 
basis of precisely measured masses; (tr) – traces; compounds detected by mass spectrometer 
No. tR / min Measured molecular mass and measured mass of m/z ions Molecular formula 
1 4.275 444.2202; 445.2275 C19H32N4O8 
2 5.706 472.2556; 473,2628 C21H36N4O8 
3 7.464 414.2130; 415.2203 + 394.1154; 395.1227 + 378.1411; 379.1484 C23H30N2O5 + C21H18N2O6 or 
C16H18N4O8 + C18H22N2O7 
6 8.843 278.1496; 279.1568; 301.1390; 317.1138 C16H22O4 or C17H18N4 
7 13.564 406.1271; 407.1343, 100% (409.1328, 30%); 429.1172, 100% 
(431.1155, 30%); 445.0909, 100% (447.0932, 30%) 
C20H23N2O5Cl 
8 17.282 290.2437; 291.2507; 308.2777; 313.2328; 329.2084 C16H34O4 or C17H30N4 
9 21.600 255.2543; 256.2615; 273.2879; 278.2434; 294.2168; 511.5183; 
533.5006 
C16H33NO 
10 24.725 408.1431; 409.1496, 100% (411.1475, 30%); 431.1327, 100% 
(433.1301, 30%) 
C20H25N2O5Cl (amlodipine) 
11 26.988 281.2701; 282.2770; 299.3031; 304.2599; 563.5500 C18H35NO 
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radation of amlodipine besylate should be carried out. 
This will be the subject of our further investigation.  
CONCLUSION 
The proposed study describes an isocratic, 
reversed-phase liquid chromatographic method for 
investigation of degradation products of amlodipine 
besylate under the stressed conditions in solution. 
Amlodipine-besylate stock solutions were subjected 
to acid and alkali hydrolysis, chemical oxidation and 
photo degradation as well as to the electrochemical 
degradation by cyclic voltammetry in 0.05 mol/L 
NaHCO3 on gold electrode. The study showed the 
complete degradation of amlodipine besylate in 5 
mol/L NaOH at 80 °C for 6 h, whereas moderately 
degraded in alkali 0.1 mol/L NaOH at 80 °C for 6 h 
(42.0%) and photo UV/Vis for 14 days (32.2%) con-
ditions. Under the acid conditions, amlodipine besyl-
ate was degraded up to 75.2%. The drug was highly 
degraded in oxidative (80.1%) conditions. By cyclic 
voltammetry, 66.5% of amlodipine besylate degrad-
ation was achieved. After 9 h of cyclization the vol-
tammogram shows that the beginning of amlodipine 
oxidation was shifted for 200 mV to more negative 
potentials. In addition, using of mass spectrometry 
technique we identified the presence of dehydro 
amlodipine derivate C20H23N2O5Cl as one of the 
forced degradation products in oxidative and acidic 
degradation of amlodipine. 
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NAUČNI RAD 
  ISPITIVANJE DEGRADACIONIH PROIZVODA 
AMLODIPIN-BEZILATA PRIMENOM TEČNE 
HROMATOGRAFIJE I TEČNE HROMATOGRAFIJE-
MASENE SPEKTROMETRIJE U USLOVIMA 
FORSIRANE I POTPUNE DEGRADACIJE 
Primenjena je izokratska RP-HPLC metoda za ispitivanje degradacionih proizvoda amlo-
dipin-bezilata u uslovima forsirane degradacije. Osnovni rastvori amlodipin-bezilata su 
podvrgnuti kiseloj i alkalnoj hidrolizi, hemijskoj i fotodegradaciji kao i elektrohemijskoj deg-
radaciji primenom ciklične voltametrije u rastvoru 0,05 mol/L NaHCO3 na elektrodi od zlata. 
Potpuna degradacija amlodipin-bezilata je postignuta u 5 mol/L NaOH na 80 °C za 6 sati, a 
jedinjenje molekulske formule C15H16NOCl je identifikovano kao glavni degradacioni proiz-
vod. Pod uticajem kiseline (5 mol/L HCl) na 80 °C za 6 sati postignuto je 75,2% degra-
dacije amlodipin-bezilata. U uslovima oksidativnog stresa u rastvoru 3% H2O2-metanol 
80:20 na 80 °C tokom 6 sati pokazana je degradacija od 80,1%.  Nakon 14 dana izlaganja 
rastvora amlodipin-bezilata fotodegradaciji u komori za fotostabilnost postignuta je degra-
dacija od 32,2%. Kod elektrohemijske degradacije posle 9 sati ciklizacije početak oksida-
cije amlodipina se pomerio za 200 mV ka negativnijim potencijalima, sa degradacijom od 
66,5%. Masenom spektrometrijom potvrđeno je prisustvo dehidro derivata amlodipina 
molekulske formule C20H23N2O5Cl kao proizvoda forsirane degradacije u uslovima oksi-
dacije i degradacije u kiseloj sredini. Pri elektrohemijskoj degradaciji amlodipina ovo jedi-
njenje nađeno je u tragovima. 
Ključne reči: amlodipin-bezilat, forsirana degradacija, reverzno fazna tečna hro-
matografija, tečna hromatografija-masena spektrometrija. 
 
 
